← All organizations

Interleukin Genetics

For profit

Phase 1 Phase 2 Phase 3 Phase 4

First clinical trial

Last known activity

Oct 1, 2004

Acquired by ORIG3N on Nov 22, 2017

Timeline

1990s

Jun 1, 1997
Interleukin Genetics— Founded

2010s

Nov 22, 2017
ORIG3N— Acquired By

Drugs by trial phase (4 distinct, 1 trials)

Other trials (4 own, 0 via acquisition)

Recent trials (1)

NCT00303238Study directorN/AOct 1, 2004

Details

Founded: Waltham, MA, US Jun 1, 1997
Last known activity: Oct 1, 2004